Ph.D.


Research Scholar: Professor John Clapp

UConn Professor John Clapp, of West Hartford, Named Kinnard Distinguished Research Scholar

Hartford Courant – UConn Professor John Clapp, who has been recognized as one of the top real estate researchers in the world, has been named the first Kinnard Distinguished Research Scholar in the business school’s Center for Real Estate.


Time to Flex

Giving Workers More Control of Their Time May Be Good for All

Rep-Am.com – When she first began working there 15 years ago, Beekley Corp. in Bristol was a fairly traditional company. “We were of the mind that everybody needed to be here, 9 to 5,” said Maureen O. Gallo, vice president of human assets and operational excellence at the medical supply company. But when the company began asking its employees what it could do to make them perform at their highest level, one fact was clear: They wanted flexibility.



Why Certain Managers Thrive

Why Certain Managers Thrive in Tough New Jobs While Others Get Fed Up
Harvard Business Review – Career development is supposed to keep young managers engaged and motivated, but sometimes it backfires, prompting them to start looking for an exit from the company. That’s because the new responsibilities that facilitate on-the-job learning can take them well beyond their comfort zones, making them feel frustrated, angry, or fearful of failure.


Report Finds “Conflicts of Interest” Have No Effect on FDA Advisory Committee Votes

Policy and Medicine – Stringent conflicts-of-interest policies keep many experts off of FDA advisory committees. A new study suggests that the fear of pro-industry bias underlying these policies may be misplaced, and also serves to keep highly qualified candidates off of these committees.

James C. Cooper, director of research and policy at the Law and Economics Center at George Mason Law School and Joseph Golec, professor of Finance of the University of Connecticut, who conducted the study, sought to compare conflicted members’ voting patterns with objective criteria. They found that decisions by advisory committees with conflicted members to recommend drugs were more likely to be consistent with both the ultimate FDA decision as well as stock market predictions than non-conflicted advisory committees and members.